Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
Doctors with disabilities call for a paradigm shift to make medical education, profession more inclusive

Doctors with disabilities call for a paradigm shift to make medical education, profession more inclusive

New cell injection technique could help reverse forms of vision loss

New cell injection technique could help reverse forms of vision loss

New nanoparticle-based artificial retina prosthesis restores vision in blind rats

New nanoparticle-based artificial retina prosthesis restores vision in blind rats

Researchers develop artificial liquid retinal prosthesis to counteract the effects of eye disorders

Researchers develop artificial liquid retinal prosthesis to counteract the effects of eye disorders

Hungarian physician to receive the Körber Prize for European Science 2020

Hungarian physician to receive the Körber Prize for European Science 2020

Researchers question the mechanism of retinitis pigmentosa

Researchers question the mechanism of retinitis pigmentosa

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Research pinpoints potential new therapeutic target for retinal degeneration

Research pinpoints potential new therapeutic target for retinal degeneration

Reprogramming skin cells into photoreceptors to restore vision in mice

Reprogramming skin cells into photoreceptors to restore vision in mice

Researchers restore sight in mice by turning skin cells into light-sensing eye cells

Researchers restore sight in mice by turning skin cells into light-sensing eye cells

Abnormal retinal gene function underlying vision loss in dogs

Abnormal retinal gene function underlying vision loss in dogs

Preclinical data of Ocugen's OCU400 genetic modifier published in Nature Gene Therapy

Preclinical data of Ocugen's OCU400 genetic modifier published in Nature Gene Therapy

New gene therapy improves vision in blind mice

New gene therapy improves vision in blind mice

Gene therapy approach could pave the way for treatment of Stargardt disease

Gene therapy approach could pave the way for treatment of Stargardt disease

Researchers identify novel cellular entry factor for AAV vector types

Researchers identify novel cellular entry factor for AAV vector types

UPMC implants first patient in the U.S. with new wireless retinal device

UPMC implants first patient in the U.S. with new wireless retinal device

Researchers report first structural model for key enzyme associated with inherited eye diseases

Researchers report first structural model for key enzyme associated with inherited eye diseases

Exploring the link between macular degeneration and retinitis pigmentosa

Exploring the link between macular degeneration and retinitis pigmentosa

New imaging methods provide unprecedented close-up view of cilia linked to blindness

New imaging methods provide unprecedented close-up view of cilia linked to blindness

Discovery in monkeys could pave way for treatment of Bardet-Biedl Syndrome

Discovery in monkeys could pave way for treatment of Bardet-Biedl Syndrome